BioCity Nottingham appoints life sciences industry leader Dr John
Brown to board
13 March 2012
BioCity Nottingham Ltd, which runs one of Europe’s largest
bioscience business incubators, has appointed Dr John Brown CBE FRSE as
a non-executive Director to its Board.
His arrival closely follows the launch of BioCity Scotland, and
marks another step-change in the growth ambitions of the company.
Dr Brown brings extensive experience in the life sciences sector;
he is currently Chairman of CXR Biosciences Ltd, and a non-executive
Director of Vectura Group PLC. Dr Brown also plays a major role in
public sector life sciences organisations. He chairs the Roslin
Foundation, co-chairs the Life Sciences Industry Advisory Board for
the Scottish Government and is a non-executive Director of the
Technology Strategy Board. Dr Brown was appointed CBE for services
to Science in June 2011.
Dr Brown has served as a Director of several private and public
life science companies. Most recently he was Chairman of BTG plc and
Axis-Shield plc. Early in his career Dr Brown spent five years with
Glaxo Group Research where he published extensively on neuropeptide
antagonists. Subsequently he worked in equity research, and in
advising biotechnology, pharmaceutical companies, and investment
In 1995 he joined Acambis PLC, a leading producer of vaccines to
treat and prevent infectious diseases, and held the post of chief
executive from 1997 to 2003. Under his leadership he took the
company through public flotation to become one of the UK’s most
successful, and profitable, biotechnology businesses.
Commenting on his appointment to the BioCity Nottingham board Dr
Brown said, “I’m delighted to be working with the BioCity team.
Emulating the successful BioCity model at BioCity Scotland is just
the first step for a company with exceptional growth potential.’’
Dr Louis Nisbet, BioCity Chairman said, “We are delighted to
welcome John to the Board of BioCity Nottingham Ltd. It will be
immensely valuable to draw on his extensive experience as our
organisation continues to grow as a leading provider of incubation
facilities and services to start-up and fast growing life sciences
companies. Few individuals have the depth and breadth of experience
that he will bring to BioCity and to the companies we support.”